京東方A(000725.SZ):第8.6代AMOLED生產線項目分兩期分階段建設 預計2026年底量產
格隆匯1月24日丨京東方A(000725.SZ)1月23日在接待機構投資者調研時表示,通過投資第8.6代AMOLED生產線項目,公司建設全球首批高世代AMOLED半導體顯示生產線,有望同步國際同業所推出產品,搶佔高世代AMOLED半導體顯示“藍海”的戰略機遇,進一步提升公司半導體顯示整體競爭力,鞏固行業地位。同時,公司聯合國內外眾多知名品牌,共同推進中尺寸IT類產品向OLED屏的升級換代,開拓中尺寸OLED屏幕產品的廣闊市場。
公司第8.6代AMOLED生產線項目分兩期分階段建設,預計2026年底量產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.